According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...

NeoGenomics’ third quarter results were met with a negative market reaction, as shares declined following the announcement. Management attributed the quarter’s performance to robust growth in clinical ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

A global team of experts from academia and industry has joined forces in a landmark Consensus Statement on next-generation ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

"These RNAs seem to act like postal codes for gene repression," said Dr. Anuj K. Verma, lead author of the study. "They help direct the polycomb complex to precise chromatin neighborhoods where stress ...

MedGenome, a leading global genomics-driven diagnostics and research services company, has announced a majority investment in Gujarat-headquartered pathology laboratory chain, Green Cross Genetics Lab ...

In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...

Featuring the next-generation myUnity ® electronic health record (EHR ... that helps organizations verify coverage by detecting secondary and tertiary payers, sequencing them for the services provided ...

Veracyte, Inc. , a leading genomic diagnostics company, today announced the publication of two studies demonstrating the Afirma GRID (Genomic Resource for Intelligent Discovery) research tool's ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.